? Defining novel therapeutic strategies for relapsed ovarian cancer

Defining novel therapeutic strategies for relapsed ovarian cancer

    NAME Dr Elaine Sanij
    CANCER TYPE Ovarian
    INSTITUTION Peter MacCallum Cancer Centre
    STATE Victoria
    GRANT TYPE $100,000
    PROJECT TYPE Research

    Defining novel therapeutic strategies for relapsed ovarian cancer

    High-grade serous ovarian cancer accounts for 70% of ovarian cancer . Despite good initial responses to chemotherapy, recurrence is common and its five-year survival rate of 43% has not improved over the past three decades. This project has the potential to establish a new treatment paradigm for this disease of high therapeutic need.


    Best Replica Watches perfect-clones.com Rolex Replica Watches Replica Watches Audemars Piguet Replica Watches Richard Mille Replica